Benzinga’s Top Pre-Market Losers (AFFY, PSEC, PPL, TJX)

Affymax Inc AFFY tumbled 52.46% to $ $10.94 in the pre-market session. AFFY’s experimental drug for treating patients suffering from anemia with chronic renal failure has achieved its target in four late-stage studies. Prospect Capital Corporation PSEC lost 5.24% to $10.30 in the pre-market session. A senior secured investment worth $6 million has been made by PSEC in a leading private-equity-owned firm that provides services to the steel products industry. PPL Corporation PPL fell 0.23% to $26.00 in the pre-market session. PPL is simultaneously offering its 90 million common shares and $1.0 billion-worth equity unit securities. The TJX Companies Inc TJX slipped 0.07% to $45.93 in pre-market trading. TJX was trading above its 20-day, 50-day and 200-day moving averages on Friday. Read more from Benzinga's Company news.